+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

  • ID: 4775589
  • Report
  • June 2019
  • Region: Global
  • 106 pages
  • IMARC Group
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • Bio SB
  • Cell Signaling Technology
  • Merck
  • Roche
  • MORE
The global tissue diagnostics market reached a value of US$ 3.8 Billion in 2018. Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services. Looking forward, the publisher expects the market to reach a value of US$ 5.5 Billion by 2024, registering a CAGR of 6.5% during 2019-2024.

Report Coverage:

Historical, Current and Future Market Trends

Market Breakup by Product Type:
Instruments
Consumables

Market Breakup by Technology:
Immunohistochemistry
In Situ Hybridization
Digital Pathology and Workflow Management
Special Staining

Market Breakup by Disease:
Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-Small Cell Lung Cancer
Others

Market Breakup by End-User:
Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Others

Market Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc

Key Questions Answered in This Report:

How has the global tissue diagnostics market performed so far and how will it perform in the coming years?
What are the key regional markets in the global tissue diagnostics industry?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the disease?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global tissue diagnostics industry?
What are the key driving factors and challenges in the global tissue diagnostics industry?
What is the structure of the global tissue diagnostics industry and who are the key players?
What is the degree of competition in the global tissue diagnostics industry?
What are the profit margins in the global tissue diagnostics industry?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • Bio SB
  • Cell Signaling Technology
  • Merck
  • Roche
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Tissue Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product Type
5.4 Market Breakup by Technology
5.5 Market Breakup by Disease
5.6 Market Breakup by End-User
5.7 Market Breakup by Region
5.8 Market Forecast

6 Market Breakup by Product Type
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Technology
7.1 Immunohistochemistry
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 In Situ Hybridization
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Digital Pathology and Workflow Management
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Special Staining
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by Disease
8.1 Breast Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Gastric Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Lymphoma
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Prostate Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Non-Small Cell Lung Cancer
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast

9 Market Breakup by End-User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Contract Research Organizations
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis
14.1 Price Indicators
14.2 Price Structure
14.3 Margin Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Roche
15.3.2 Danaher
15.3.3 Thermo Fisher Scientific
15.3.4 Abbott
15.3.5 Agilent Technologies
15.3.6 Merck
15.3.7 Sakura Finetek Japan
15.3.8 Abcam
15.3.9 BD
15.3.10 Qiagen
15.3.11 Bio SB
15.3.12 Biogenex
15.3.13 Cell Signaling Technology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Roche
  • Danaher
  • Thermo Fisher Scientific
  • Abbott
  • Agilent Technologies
  • Merck
  • Sakura Finetek Japan
  • Abcam
  • BD
  • Qiagen
  • Bio SB
  • Biogenex
  • Cell Signaling Technology
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll